Skip to main content
Equibles

Metis Global Partners, LLC

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1594916 San Diego, CA
Back to ALNY Full portfolio

Position in ALNY

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,206,829
-$132,863 QoQ
Shares Held
4,009
-1.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#377
of 788 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in ALNY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Metis Global Partners, LLC holds $12,809,533 across 8 Biotechnology names. ALNY ranks #4 (9.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,929 $5,428,762
2 RPRX
Royalty Pharma plc
 59,374 $3,329,100
3 REGN
Regeneron Pharmaceuticals, Inc.
 2,439 $1,520,814
4 ALNY
Alnylam Pharmaceuticals, Inc.
This page 		4,009 $1,206,829
5 INCY
Incyte Corp
 4,068 $461,148
6 MRNA
Moderna, Inc.
 6,452 $451,833
7 TECH
BIO-TECHNE Corp
 2,918 $206,156
8 PBYI
Puma Biotechnology, Inc.
 25,264 $204,891

All Filings in ALNY

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,206,829 4,009
2026-03-31 $1,339,692 4,049
2025-12-31 $1,664,165 4,185
2025-09-30 $1,965,816 4,311
2025-06-30 $1,512,079 4,637
2025-03-31 $1,502,931 5,566
2024-12-31 $1,112,310 4,727
2024-09-30 $1,204,631 4,380
2024-06-30 $722,925 2,975
2024-03-31 $439,383 2,940
2023-12-31 $838,758 4,382
2023-09-30 $759,404 4,288
2023-06-30 $749,503 3,946
2023-03-31 $730,366 3,646
2022-12-31 $594,600 2,502
2022-09-30 $269,215 1,345